Medical Device Industry News

MassDevice.com +3 | The top 3 medtech stories for July 24, 2014

July 24, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Elekta eyes Turkish radiology market with acquisition of Mesi Medikal

July 24, 2014 by Arezu Sarvestani

Elekta hopes to meet Turkey's radiotherapy "shortage" through its acquisition of local distributor Mesi Medikal.

Elekta eyes Turkish radiology market with acquisition of Mesi Medikal

Press Release: Boston Scientific receives CE Mark for Agent drug-coated balloon

July 24, 2014 by Arezu Sarvestani

Innovative technology adds to company's leading portfolio of treatment options for coronary artery disease.

Press Release: Boston Scientific receives CE Mark for Agent drug-coated balloon

Boston Scientific lands another E.U. win, this time for Agent balloon

July 24, 2014 by Arezu Sarvestani

Boston Scientific is on a regulatory roll, now touting CE Mark approval for its Agent drug-coated balloon for treatment of coronary artery disease.

Boston Scientific lands another E.U. win, this time for Agent balloon

Boston Scientific (NYSE:BSX) added another product to its recent string of regulatory approvals, announcing European CE Mark approval and immediate commercial launch for the company's Agent paclitaxel-coated balloon catheter.

Report: Surgical robots may be moot in cystectomy

July 24, 2014 by Arezu Sarvestani

Robot-assisted surgical devices maker Intuitive Surgical takes offense as doctors at a major U.S. cancer center warn that robot-assisted surgery may have little to offer patients undergoing surgical bladder removal.

Report: Surgical robots may be moot in cystectomy

The much-disputed field of robot-assisted surgery took another blow this week when doctors from Memorial Sloan Kettering Cancer Center warned that the high-tech procedure may be no better than traditional surgery for patients with invasive bladder cancer.

Report: Medtronic shareholder sues to block Covidien merger

July 24, 2014 by Brad Perriello

A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.

Report: Medtronic shareholder sues to block Covidien merger

Abbott CEO chides critics of corporate inversions | Medtech Wall Street news for the week of July 21, 2014

July 24, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Abbott CEO defends inversions amid corporate exodus furor; Medtronic fights tax dodging rhetoric in Covidien merger; Allergan cuts 1,500 jobs, faces SEC complaint; A countdown to failure for Valeant's hostile $53B Allergan takeover; GE Healthcare idles for another quarter

Abbott CEO defends inversions amid corporate exodus furor

July 18, 2014 by Arezu Sarvestani

Abbott CEO defends inversions amid corporate exodus furor
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp